Additionally, CCL20 can induce cell migration and epithelial-mesenchymal transition (EMT) through the PI3K/AKT and Wnt/β-catenin pathways, thereby promoting tumor growth and predicting low survival rates and tumor recurrence in hepatocellular carcinoma patients (39). Here, AKT1 is linked to hepatocellular carcinoma.